Bienvenido a EPG Patient Direct

El portal sobre salud para pacientes y para el público en general en Europa

Welcome
  • Estados y enfermedades
  • Administrar su salud
  • Consejo sobre el estilo de vida
  • Opciones de tratamiento

Noticias De la Salud

Health News

Observe por favor que estas noticias están en web site externos.

Your Vote

There is currently no poll for this section.

 

Este servicio contiene enlaces a sitios Web de terceros. EPG Patient Direct no comprueba la información allí presentada y no puede considerarse responsable de la fidelidad de los contenidos.

   

Health News ArchiveEPG Patient Direct Health News

Steroid drug offers hope to MS patients

01 May 2009

Multiple sclerosis (MS) patients who use a steroid drug in addition to an MS drug may reduce the disease's symptoms more than if they use the MS drug in isolation, a new study has suggested.

Researchers from the Danish Multiple Sclerosis Research Center at Copenhagen University Hospital, Denmark, found that MS patients who received methylprednisolone in monthly 'pulses', or three doses over three days, in addition to MS drug interferon beta-1a, were less likely to experience relapses.

Study author Mads Ravnborg said the results suggest that the drugs "may have a synergy when taken together".

"This is a promising finding, as the benefit from interferon is only moderate and not everyone responds fully to the treatment, so anything we can do to boost those results is positive," he explained.

During the study, participants who received both drugs had 38 per cent fewer relapses than patients who were only receiving the interferon drug, while they also showed improvements on MS disability tests.

MS is five times more prevalent in temperate climates than in tropical climates.

Click here to visit the Multiple Sclerosis Quick GuideADNFCR-1528-ID-19149822-ADNFCR

Email article E-mail    Bookmark Bookmark    Print Article Print

Delicious   Reddit Reddit   Facebook Facebook   StumbleUpon StumbleUpon  

Related Multiple Sclerosis News